Technology, Therapy Area

Journal 2019, Issue 44

By NSF International, Pharmaceutical Services

Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.

Emerging pharma hubs are springing up across the world and this provides us with many more options on where to place our valuable assets.

NSF is noticing a trend where a variety of pharma companies want a third-party perspective on the suitability of an outsourcing option, seeking a thorough and impartial assessment of risk, distinctly outside of the influence of internal politics and financial targets.

From such a review, NSF can measure the resource burden of setting up and providing ongoing monitoring of the outsourced location, the inherent risks and how to identify and manage them effectively.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.